MOHALI: In view of the COVID-19 pandemic condition that the world is facing today pharmaceutical researchers, scientists, and healthcare professionals got together at an international meet on “Pharmaceutical care, Management Prospectives of COVID-19 pandemic”.
Participating in a two-day international e-conference-2020, organised by the Rayat Bahra University School of Pharmaceutical Sciences in collaboration with Association of Pharmaceutical Teachers of India (APTI), which concluded here today, experts underlined the need to make inter-disciplinary work approach in order to overcome the difficulties associated with drug discovery.
Gurvinder Singh Bahra, Chancellor of the Rayat Bahra University, welcomed the delegates and expressed hope that the scholars would find the deliberations at the conference fruitful.
Prof B Suresh, President of the Pharmacy Council of India, in his presidential address laid stress on the inter-disciplinary approach which could break down the barriers between the different fields of pharmaceutical research.
Dr Daljit Singh, Vice-Chancellor of the Rayat Bahra University, in his welcome address said the Webinar was to bring together leading pharmacologists and researchers on one platform share their research experience.
Prof Shailendra Saraf, Vice-President, Pharmacy Council of India, was the chief guest. Prof Bhupinder Singh Bhoop, former Chairman and Dean, University Institute of Pharmaceutical Sciences, was the guest of honour.
Dr Gurfateh Singh, Head of the university school of pharmaceutical sciences, said he was confident that the participants had benefitted from this high value scientific programme. Over 5, 000 persons registered for the Webinar.
Various eminent personalities including professors, pharmacologists and physicians form prestigious organizations like Panjab University, Chandigarh, Punjabi University, Patiala, AIIMS Delhi, PGIMER Chandigarh, NIPER Mohali, Utrakhand Ayurvedic University, Medicinal Plant Board, GESCO Healthcare Pvt Ltd, Chennai, and College of Medicine, Texas, A and M University, Texas, USA, shared the recent updates on pharmaceutical care, management approaches, and future research on COVID-19.